Pristiq is not an MAOI. It belongs to a completely different class of antidepressants called SNRIs, or serotonin and norepinephrine reuptake inhibitors. The distinction matters because these two drug classes work through different mechanisms, carry different risks, and must never be taken together.
How Pristiq Works
Pristiq (desvenlafaxine) is FDA-approved for the treatment of major depressive disorder. It works by blocking the reabsorption of two chemical messengers in the brain: serotonin and norepinephrine. When these chemicals stay active longer in the spaces between nerve cells, mood and energy levels can improve. This reuptake-blocking mechanism is fundamentally different from how MAOIs work.
Testing during drug development confirmed that Pristiq has no monoamine oxidase inhibitory activity whatsoever. It simply does not interact with the MAO enzyme. Other well-known SNRIs include venlafaxine (Effexor) and duloxetine (Cymbalta).
How MAOIs Differ
MAOIs work by blocking an enzyme called monoamine oxidase, which normally breaks down serotonin, norepinephrine, and dopamine in the brain. By disabling this enzyme, MAOIs allow those chemicals to build up. The MAOIs prescribed for depression include isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Emsam), and tranylcypromine (Parnate).
One practical consequence of disabling the MAO enzyme is that it also stops the body from breaking down tyramine, a compound found in aged cheeses, cured meats, fermented foods, and certain beverages. A dangerous spike in blood pressure can result if tyramine builds up unchecked, so people taking MAOIs must follow a strict low-tyramine diet. Pristiq does not require any dietary restrictions because it leaves the MAO enzyme untouched.
Why Pristiq and MAOIs Can’t Be Combined
Even though Pristiq is not an MAOI, the two drugs are dangerous together. Both increase serotonin levels through different pathways, and combining them can push serotonin to toxic levels. This causes a potentially life-threatening condition called serotonin syndrome.
Symptoms of serotonin syndrome include tremor, muscle rigidity, seizures, rapid fluctuations in heart rate and blood pressure, high fever, extreme agitation, and in severe cases, delirium or coma. The FDA lists the combination as a hard contraindication, meaning it should never be done.
Required Waiting Periods When Switching
If you’re transitioning between Pristiq and an MAOI in either direction, a drug-free washout period is required to let the first medication fully clear your system before starting the other.
- Stopping an MAOI before starting Pristiq: Wait at least 14 days after your last MAOI dose.
- Stopping Pristiq before starting an MAOI: Wait at least 7 days after your last Pristiq dose.
The difference in timing reflects how long each drug remains active in the body. Pristiq clears faster than most MAOIs. Cross-tapering, where you gradually lower one drug while raising the other, is not recommended here because of the high risk of serotonin syndrome during any period of overlap. The NHS Specialist Pharmacy Service notes that switching between these classes should be done with specialist guidance, and the exact washout duration may be adjusted on a case-by-case basis depending on which MAOI is involved.
Why People Confuse the Two
The confusion often comes from the fact that both Pristiq and MAOIs treat depression and both affect the same brain chemicals. Their names also appear together frequently in prescribing warnings, which can make it seem like they’re related. In reality, the warnings exist precisely because they are so different in how they raise serotonin levels that combining them creates a dangerous surplus the body can’t regulate safely.